All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99
Paper Submission

Why Us? >>
- Open Access
- Peer-reviewed
- Rapid publication
- Lifetime hosting
- Free indexing service
- Free promotion service
- More...
- Search engine friendly

Archive of "Vaccines".

ISSN Print: 2076-393X

ISSN Online:

Website: https://www.ncbi.nlm.nih.gov/pmc/journals/2764/

Share:




Go

Development of Luciferase Immunoprecipitation Systems (LIPS) Assay to Detect IgG Antibodies against Human Respiratory Syncytial Virus G-Glycoprotein

Ashwin Kulkarni,Judy Beeler,Priyanka Jayanti,Roberta Lynne Crim,Sangeeta Kumari,Susette Audet

Differential Response Following Infection of Mouse CNS with Virulent and Attenuated Vaccinia Virus Strains

Boaz Politi,Einat B. Vitner,Galia Zaide,Hadas Tamir,Hagit Achdout,Inbar Cohen-Gihon,Lilach Cherry,Nir Paran,Noam Erez,Ofir Israeli,Sharon Melamed,Shlomo Lustig,Tomer Israely

The Modified Vaccination Technique

Arpad Barabas,Chad Cole,Erno Kovacs,Rene Lafreniere,Zoltan Kovacs

Attenuation and Stability of CHIKV-NoLS, a Live-Attenuated Chikungunya Virus Vaccine Candidate

Adam Taylor,Ali Zaid,Eranga Abeyratne,Joseph R. Freitas,Suresh Mahalingam

DNA-Protein Vaccination Strategy Does Not Protect from Challenge with African Swine Fever Virus Armenia 2007 Strain

Daniel Madden,Daniel Pérez-Nú？ez,Elena G. Sánchez,Igor Morozov,In Joong Kim,Jessie D. Trujillo,Juergen A. Richt,Kinga Urbaniak,Lina Mur,Marisa Nogal,Natasha N. Gaudreault,Sun-Young Sunwoo,Wenjun Ma,Yolanda Revilla

Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein–Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor Growth

Alfredo Perales-Puchalt,David B. Weiner,Krzysztof Wojtak

Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design

Aadil El-Turabi,Ariane C. Gomes,E. S. Roesti,Martin F. Bachmann

Designed DNA-Encoded IL-36 Gamma Acts as a Potent Molecular Adjuvant Enhancing Zika Synthetic DNA Vaccine-Induced Immunity and Protection in a Lethal Challenge Model

Daniel O. Villarreal,David B. Weiner,Hyeree Choi,Kar Muthumani,Lumena Louis,Megan C. Wise

Evaluation of a Recombinant Mouse X Pig Chimeric Anti-Porcine DEC205 Antibody Fused with Structural and Nonstructural Peptides of PRRS Virus

Jesús Hernández,Lorena Bustamante-Córdova,Mónica Reséndiz-Sandoval

Plasmid DNA-Based Alphavirus Vaccines

Kenneth Lundstrom

Erratum: Thadi A.; et al. Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis. Vaccines 2018, 6, 54

Anusha Thadi,Marian Khalili,Scott D. Richard,Steven C. Katz,Wilbur B. Bowne,William F. Morano

Role of Type I Interferons on Filovirus Pathogenesis

Beatriz Escudero-Pérez,César Mu？oz-Fontela

Comment on “Effectiveness of a Group B outer membrane vesicle meningococcal vaccine in preventing hospitalization from gonorrhea in New Zealand: a retrospective cohort study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005”

Chris Kenyon

Complementary Role of CD4+ T Cells in Response to Pneumococcal Polysaccharide Vaccines in Humans

Edward N. Janoff,Vibha Jha

Feasibility Analysis of Interleukin-13 as a Target for a Therapeutic Vaccine

Aleksandra Mol？da,John Foerster

Knowledge and Perceptions of Adverse Events Following Immunization among Healthcare Professionals in Africa: A Case Study from Ghana

Frasia Oosthuizen,Peter Yamoah,Varsha Bangalee

Time to Micromanage the Pathogen-Host-Vector Interface: Considerations for Vaccine Development

Jessica E. Manning,Tineke Cantaert

Utility of the Neonatal Calf Model for Testing Vaccines and Intervention Strategies for Use against Human RSV Infection

Jodi L. McGill,Mariana Guerra-Maupome,Mitchell V. Palmer,Randy E. Sacco

The Role of Serotype-Specific Immunological Memory in Pneumococcal Vaccination: Current Knowledge and Future Prospects

Ioanna Papadatou,Irene Tzovara,Paul V. Licciardi

T-Cell Response to Viral Hemorrhagic Fevers

Federico Perdomo-Celis,Juan C. Zapata,Maria S. Salvato,Sandra Medina-Moreno

Subunit Vaccine Approaches for African Swine Fever Virus

Juergen A. Richt,Natasha N. Gaudreault

New Rabies Vaccines for Use in Humans

Hildegund C. J. Ertl

Computational Approaches and Challenges to Developing Universal Influenza Vaccines

Justin Bahl,Venkata R. Duvvuri,Xueting Qiu

A Comparison of Plasmid DNA and mRNA as Vaccine Technologies

Margaret A. Liu

Current and Novel Approaches in Influenza Management

Deimante Lukosaityte,Erasmus Kotey,Gordon Awandare,Munir Iqbal,Osbourne Quaye,William Ampofo

Use of a Novel Enhanced DNA Vaccine Vector for Preclinical Virus Vaccine Investigation

Edward P. Rybicki,Rosamund Chapman

A HER2-Displaying Virus-Like Particle Vaccine Protects from Challenge with Mammary Carcinoma Cells in a Mouse Model

Adolfo García-Sastre,Clemens Grünwald-Gruber,Florian Krammer,Guha Asthagiri Arunkumar,Krisztina Koczka,Lisa Nika,Meagan McMahon,Reingard Grabherr,Sara Cuadrado-Castano

Combating Vaccine Hesitancy with Vaccine-Preventable Disease Familiarization: An Interview and Curriculum Intervention for College Students

Brian D. Poole,Deborah K. Johnson,Emily J. Mello,Jamie L. Jensen,Spencer J. Hood,Trent D. Walker

20th International Conference on Emerging Infectious Diseases in the Pacific Rim Organized by the United States-Japan Cooperative Medical Sciences Program (USJCMSP)

Aikichi Iwamoto,Diane E. Griffin,F. Gray Handley,Florian Krammer,George F. Gao,Ichiro Kurane,K. Gayle Bernabe,Kristina T. Lu,USJCMSP AIDS, ARI, Cancer, Hepatitis, Immunology and Viral Diseases Panels

Bacterial Outer Membrane Vesicles (OMVs)-Based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV

Ahmed Kandeil,Ahmed Mostafa,Ahmed Osman,Ghazi Kayali,Lisa Teubner,Luigi La Pietra,Mahmoud M. Shehata,Mobarak Abu Mraheil,Mohamed A. Ali,Rabeh Elshesheny,Renate Frantz,Sara H. Mahmoud,Stephan Pleschka,Thamer A. Boubak,Trinad Chakraborty

Reply to “Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005”

Felicity Goodyear-Smith,Helen Petousis-Harris,Jane Morgan,Janine Paynter,Peter Saxton,Steven Black

Will Attention by Vaccine Developers to the Host’s Nuclear Hormone Levels and Immunocompetence Improve Vaccine Success?

Bart G. Jones,Geoff Neale,Julia L. Hurwitz,Rhiannon R. Penkert,Robert E. Sealy,Sherri L. Surman,Stephane Pelletier

New Promising Targets for Synthetic Omptin-Based Peptide Vaccine against Gram-Negative Pathogens

Anna M. Lyapina,Lidiya V. Sayapina,Maria A. Khizhnyakova,Onega V. Ulianova,Sergey S. Ulyanov,Sergey S. Zaitsev,Valentina A. Feodorova,Vladimir L. Motin

In silico Designed Ebola Virus T-Cell Multi-Epitope DNA Vaccine Constructions Are Immunogenic in Mice

Alexander A. Ilyichev,Denis V. Antonets,Ekaterina V. Starostina,Larisa I. Karpenko,Olga N. Kaplina,Sergei G. Dudko,Sergei I. Bazhan,Sofia A. Fedotova,Svetlana F. Oreshkova

Novel Protein-Based Pneumococcal Vaccines: Assessing the Use of Distinct Protein Fragments Instead of Full-Length Proteins as Vaccine Antigens

John Routsias,Paraskevi Basdeki,Theano Lagousi,Vana Spoulou

Pneumococcal Vaccines: Challenges and Prospects

Ioanna Papadatou,Paul Licciardi

Increased Immunogenicity of Full-Length Protein Antigens through Sortase-Mediated Coupling on the PapMV Vaccine Platform

Ariane Thérien,Caroline Garneau,Denis Leclerc,Jérome Estaquier,Marie-ève Laliberté-Gagné,Marilène Bolduc,Philippe Casault,Pierre Savard

Comparison of Immune Responses to Different Versions of VLP Associated Stabilized RSV Pre-Fusion F Protein

Adam A. Capoferri,Gretel M. Torres,Lori M. Cullen,Madelyn R. Schmidt,Trudy G. Morrison

Epitope-Specific Serological Assays for RSV: Conformation Matters

Azad Kumar,Barney S. Graham,Deepika Nair,Emily Phung,Grace L. Chen,Julie E. Ledgerwood,Kaitlyn M. Morabito,Lauren A. Chang,Man Chen,Masaru Kanekiyo,Tracy J. Ruckwardt

Analysis of State-Specific Differences in Childhood Vaccination Coverage in Rural India

Abram L. Wagner,Matthew L. Boulton,Nijika Shrivastwa

Simultaneous Administration of Recombinant Measles Viruses Expressing Respiratory Syncytial Virus Fusion (F) and Nucleo (N) Proteins Induced Humoral and Cellular Immune Responses in Cotton Rats

Akihito Sawada,Takashi Ito,Tetsuo Nakayama,Yoshiaki Yamaji,Yosuke Yasui

Heterotypic Neuraminidase Antibodies Against Different A(H1N1) Strains are Elicited after Seasonal Influenza Vaccination

Ivan Sanz,Jose Manuel Mendez-Legaza,Raúl Ortiz de Lejarazu

Should Pneumococcal Serotype 3 Be Included in Serotype-Specific Immunoassays?

Abigail Bell,Ezra Linley,Jenna F. Gritzfeld,Ray Borrow

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line

Adrian V. S. Hill,Alison Lawrie,Amy Flaxman,Angela Minassian,Catherine Mair,Celia Mitton,Chris Ellis,Duncan Bellamy,Fernando Ramos Lopez,Ian Poulton,Katie J. Ewer,Megan Baker,Pedro M. Folegatti,Rachel Roberts,Raquel L. Ramon,Sarah C. Gilbert,Thomas G. Evans

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine

Adrian V.S. Hill,Alison M. Lawrie,Catherine F. Mair,Celia H. Mitton,Duncan Bellamy,Eleanor Berrie,Georgina Bowyer,Ian Poulton,John Hermon-Taylor,Jonathan Powlson,Katie J. Ewer,Nick J. Edwards,Nicky Green,Pedro M. Folegatti,Rachel Roberts,Sarah C. Gilbert

PCV7- and PCV10-Vaccinated Otitis-Prone Children in New Zealand Have Similar Pneumococcal and Haemophilus influenzae Densities in Their Nasopharynx and Middle Ear

Caitlyn M. Granland,Camilla de Gier,Emma J. Best,Janessa L. Pickering,Lea-Ann S. Kirkham,Mejbah Bhuiyan,Nikki Mills,Peter C. Richmond,Ruth B. Thornton,Tony Walls

Immunogenicity and Immune Memory after a Pneumococcal Polysaccharide Vaccine Booster in a High-Risk Population Primed with 10-Valent or 13-Valent Pneumococcal Conjugate Vaccine: A Randomized Controlled Trial in Papua New Guinean Children

Anita H. J. van den Biggelaar,Birunu Nivio,Deborah Lehmann,Geraldine Masiria,Jacinta Francis,Lea-Ann Kirkham,Megan Passey,Peter Jacoby,Peter Richmond,Rebecca Ford,Sandra Wana,William S. Pomat,the 10v13v PCV Trial Team

A Chimeric Zika Virus between Viral Strains MR766 and BeH819015 Highlights a Role for E-glycan Loop in Antibody-mediated Virus Neutralization

Etienne Frumence,Gilles Gadea,Jacques-Damien Arnaud,Maria-Teresa Alvarez-Martinez,Marjolaine Roche,Philippe Desprès,Sandra Bos,Wildriss Viranaicken

Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines

Ashish C. Shrestha,Branka Grubor-Bauk,Danushka K. Wijesundara,Eric J. Gowans,Makutiro G. Masavuli,Zelalem A. Mekonnen

An Influenza Virus Hemagglutinin-Based Vaccine Platform Enables the Generation of Epitope Specific Human Cytomegalovirus Antibodies

Domenico Tortorella,Kathryn R. Stein,Maria Carolina Bermúdez-González,Mohammad Amin Behzadi,Raffael Nachbagauer,Viviana Simon

Go




©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705